Geneva, March 20 -- International Clinical Trials Registry received information related to the study (CTRI/2026/02/104918) titled 'A CLINICAL STUDY ON URDHWAGA AMLAPITTA W.S.R TO GASTROESOPHAGEAL REFLUX DISEASE GERD AND ITS MANAGEMENT WITH DASANGA KWATHA' on Feb. 26.
Study Type: Interventional
Study Design:
Randomized, Parallel Group, Active Controlled Trial Method of generating randomization sequence:Not Applicable Method of allocation concealment:Not Applicable Blinding and masking:Not Applicable
Primary Sponsor: Dr Jhilima Behera
Condition:
Health Condition 1: K219- Gastro-esophageal reflux disease without esophagitis
Recruitment Status: Not Recruiting
Phase: Phase 1/ Phase 2
Date of First Enrollment: 21-03-2026
Target...